Hostname: page-component-7dd5485656-g8tfn Total loading time: 0 Render date: 2025-10-29T05:22:36.820Z Has data issue: false hasContentIssue false

The effect of almonds on mental health and gut health: a 12-week randomised controlled trial

Published online by Cambridge University Press:  09 October 2025

L. Sartori
Affiliation:
King’s College London, Department of Nutritional Sciences
N. Argomaniz
Affiliation:
King’s College London, Department of Nutritional Sciences
D. Farsi
Affiliation:
King’s College London, Department of Nutritional Sciences
B. Bajka
Affiliation:
King’s College London, Department of Nutritional Sciences
J. Chilcot
Affiliation:
King’s College London, Department of Psychology
K. Whelan
Affiliation:
King’s College London, Department of Nutritional Sciences
E. Dimidi
Affiliation:
King’s College London, Department of Nutritional Sciences
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Whole dietary interventions may reduce symptoms of depression/anxiety (1), but adherence is difficult. Single-food interventions, like almonds, may enable improved adherence and contain micronutrients associated with cognitive benefits and have a prebiotic effect on the gut microbiome (2). This randomised controlled trial assessed the effects of whole almonds on mental and gut health in adults with mild to moderate depression/anxiety.

Adults 18-45 years with Patient Health Questionnaire Anxiety and Depression (PHQ- ADS) (3) scores of 10-29 were randomised to 56g/day whole almonds (intervention) or two iso-caloric muffins/day (control) for 12 weeks. Symptoms of depression/anxiety (primary outcome) were assessed via the PHQ-ADS. Mental health and gastrointestinal symptoms were measured using validated questionnaires. Faecal samples were analysed for short- chain fatty acids via gas-chromatography, study measures were collected at week 0 (Baseline) and week 12 (Endpoint).

Eighty-four participants were randomised (mean age 25 years, BMI 23 kg/m2, 76% female, 46% white ethnicity). Among those who completed mental health and gastrointestinal symptom assessments (n = 81), almond consumption did not significantly affect depression and anxiety symptoms (p = 0.42), mental wellbeing (p = 0.98), or stool frequency (p = 0.32). However, functional impairment was significantly improved in the almond group compared to control (p = 0.05), and participants reported significantly fewer hard stools (p < 0.001). P-values for mental health measures were calculated using linear mixed models. P-values for stool-related outcomes were calculated using a linear regression with baseline values as a covariate.

Short-chain fatty acid (SCFA) concentrations were analysed in a subset of participants who provided faecal samples (n = 64; 31 in the almond group and 33 in the control group). There were no significant between-group differences in faecal SCFA concentrations, including total SCFAs (p = 0.51), acetic (p = 0.60), propionic (p = 0.47), butyric (p = 0.60), iso-butyric (p = 0.84), iso-valeric (p = 0.84), or valeric acid (p = 0.80). p-values were calculated using ANCOVA with baseline values as a covariate.

While almonds did not significantly reduce symptoms of depression/anxiety or the majority of mental health outcomes, they improved functional impairment and reduced reports of hard stools, suggesting potential benefits for mental and gut health. Microbiome analyses are ongoing to investigate potential markers related to the gut-brain axis. Future trials should assess whether singular food interventions have efficacy in severely depressed/anxious populations.

Information

Type
Abstract
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Nutrition Society

References

Firth, J, Marx, W, Dash, S et al. (2019) Psychosom Med 81, 265280CrossRefGoogle Scholar
Creedon, AC, Dimidi, E, Hung, E et al. (2022) Am J Clin Nutr 116, 17901804CrossRefGoogle Scholar
Kroenke, K, Wu, J, Yu, Z et al. (2016) Psychosom Med 78, 716727CrossRefGoogle Scholar